Effect of bone marrow mesenchymal stem cells on IFNγ
T cells in tumor-bearing mice (
= 5). After bone marrow mesenchymal stem cell (BMSC) treatment in the pulmonary metastatic or H22 intraperitoneal hepatoma model, IFNγ+ T cells in peripheral blood white cells were detected during and after BMSC treatment. (A) IFNγ+ T-cell percentage in peripheral blood white cells of C57 mice. (B) IFNγ+ T-cell percentage in peripheral blood white cells of BALb/c mice. #
P <0.05; §
P <0.01 compared with the control group. IFNγ, interferon gamma.